Pathway |
Count |
P-value |
Proteins |
Fold Enrichment |
Bonferroni |
Benjamini |
FDR |
Oxidative phosphorylation |
24 |
8.09E-11 |
UQCRC1, ATP6AP1, ATP6V1G1, COX5A, UQCRFS1, COX5B, UQCRQ, UQCRFSL1, NDUFS7, NDUFS6, NDUFS4, ATP5L, ATP6V0D1, ATP5I, NDUFS1, NDUFA5, NDUFA2, ATP5F1, ATP6V1H, ATP6V1F, COX6C, NDUFV1, ATP6V1E1, ATP6V0A1, UQCRB |
5.18657 |
1.00E-08 |
1.00E-08 |
9.34E-08 |
Parkinson’s disease |
18 |
2.00E-06 |
NDUFA5, NDUFA2, UQCRC1, SLC25A4, ATP5F1, COX5A, VDAC2, UQCRFS1, UQCRQ, COX5B, UQCRFSL1, COX6C, VDAC1, NDUFS7, NDUFS6, NDUFS4, NDUFV1, NDUFS1, UQCRB |
3.950708 |
2.48E-04 |
1.24E-04 |
0.00231 |
Huntington’s disease |
19 |
5.51E-05 |
NDUFA5, NDUFA2, UQCRC1, SLC25A4, ATP5F1, COX5A, VDAC2, UQCRFS1, UQCRQ, COX5B, UQCRFSL1, COX6C, VDAC1, DCTN2, NDUFS7, NDUFS6, NDUFS4, NDUFV1, NDUFS1, UQCRB |
2.96547 |
0.006812 |
0.002276 |
0.063633 |
Systemic lupus erythematosus |
13 |
1.68E-04 |
HLA-DRB1, ACTN4, C4A, SNRPD3, ACTN1, HIST1H2BO, TROVE2, HIST1H2BL, HIST1H3A, H2AFY2, SNRPB, H2AFY, H3F3A |
3.689101 |
0.020611 |
0.005193 |
0.193756 |
Vibrio cholerae infection |
9 |
6.99E-04 |
ACTG1, ACTB, ATP6AP1, ATP6V1E1, ATP6V1H, ATP6V0A1, ATP6V1G1, ATP6V0D1, ATP6V1F |
4.515095 |
0.083065 |
0.017194 |
0.804307 |
Spliceosome |
13 |
0.001537 |
SNRPA1, SNRPD3, SNRPD2, HNRNPA1, NAA38, SF3B3, HNRNPU, RBM8A, PCBP1, SNRPB, MAGOHB, SNRNP70, SNRPE |
2.898579 |
0.173673 |
0.031294 |
1.760801 |
Cardiac muscle contraction |
10 |
0.001584 |
ATP1B1, ACTC1, UQCRC1, ATP1A1, UQCRFS1, COX5A, UQCRQ, COX5B, UQCRFSL1, UQCRB, COX6C |
3.601785 |
0.178439 |
0.027688 |
1.81371 |
Alzheimer’s disease |
15 |
0.001737 |
NDUFA5, NDUFA2, UQCRC1, ATP5F1, COX5A, UQCRFS1, COX5B, UQCRQ, UQCRFSL1, COX6C, NDUFS7, NDUFS6, NDUFS4, NDUFV1, NDUFS1, UQCRB |
2.58533 |
0.193896 |
0.026583 |
1.987221 |
|